Mercado de analizadores de hemostasia: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00016709
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 188
Buy Now

Se prevé que el mercado de analizadores de hemostasia alcance los 6.490,24 millones de dólares en 2028 desde los 3.440,66 millones de dólares en 2021; se espera que registre una tasa compuesta anual del 9,5 % entre 2021 y 2028.

Los analizadores de hemostasia proporcionan una medición rápida y sencilla de los niveles de plaquetas en sangre. Una prueba de coagulación podría ayudar a detectar y prevenir coágulos de sangre que podrían provocar un ataque cardíaco. Un analizador de coagulación puede medir la velocidad de la vía de coagulación y las cantidades de trombolina y tromboplastina en menos de unos pocos minutos. Es probable que las enfermedades cardiovasculares (ECV) sigan siendo la causa más importante de morbilidad y mortalidad en todo el mundo. Las ECV son trastornos del corazón y de los vasos sanguíneos e incluyen enfermedades cerebrovasculares, enfermedades coronarias, enfermedades cardíacas reumáticas y otras afecciones. Algunos problemas relacionados con el estilo de vida que provocan enfermedades y dificultades cardiovasculares son el consumo de tabaco, la alimentación poco saludable y la inactividad física. Aumentan el riesgo de ataques cardíacos y accidentes cerebrovasculares. Otros factores de riesgo de enfermedades cardiovasculares son la presión arterial alta, la diabetes y el aumento de los niveles de colesterol. Según la Organización Mundial de la Salud (OMS), las enfermedades cardiovasculares son la principal causa de muerte a nivel mundial.

Perspectivas estratégicas

regiones lucrativas para el mercado de analizadores de hemostasia

Perspectivas del mercado
Aumento de la población geriátrica para impulsar el mercado de analizadores de hemostasia

Las personas mayores son propensas a sufrir enfermedades cardíacas debido a una inmunidad débil y otras problemas de salud. Los factores generales del envejecimiento provocan un endurecimiento del corazón y de los vasos sanguíneos, lo que provoca trastornos cardíacos. A medida que avanza la edad, la presión arterial sistólica también aumenta, lo que provoca enfermedades cardiovasculares (ECV). Por lo tanto, en personas de 75 años o más, la presión arterial alta es un factor de riesgo común de enfermedades cardíacas. La enfermedad de las arterias coronarias y la insuficiencia cardíaca son las otras. Aunque la incidencia de arritmias abarca a personas de todos los grupos de edad, está aumentando significativamente entre la población geriátrica.

Según la encuesta Global Ageing 2019, la población mundial de 65 años o más ascendía a 703 millones en 2019. Se espera que el grupo demográfico de personas mayores se duplique a 1.500 millones de personas para 2050. Es probable que la frecuencia de una persona de 65 años o más aumente de 1 de cada 11 habitantes en 2019 a 1 de cada 6 habitantes en 2025. Este grupo demográfico es más susceptible a Enfermedades cardiovasculares, como arritmias. De manera similar, según la Organización Mundial de la Salud (OMS), se estima que el porcentaje de personas de 60 años o más alcanzará el 22% en 2050 desde el 12% en 2015. Según el informe "Older Americans 2016: Key Indicators of Well-Being" Según el Foro Federal Interinstitucional sobre Estadísticas Relacionadas con el Envejecimiento, el 35,8% de las personas de 85 años o más tenían un trastorno cognitivo leve o extremo. Además, según el informe sobre el envejecimiento de la población mundial 2017 de las Naciones Unidas, en 2017, 962 millones de personas tenían 60 años o más en todo el mundo, y se espera que esa cifra alcance casi 2.100 millones en 2050.

La población de edad avanzada es más propensos a presentaciones atípicas, condiciones comórbidas y resultados desfavorables. La razón principal de las enfermedades está relacionada con los cambios estructurales y funcionales en el sistema cardiovascular asociados con el envejecimiento. El aumento de la población geriátrica mundial está provocando un aumento de las enfermedades cardiovasculares, lo que, a su vez, está impulsando la demanda de analizadores de hemostasia.

Información basada en el tipo de producto

Según el tipo de producto, el mercado de analizadores de hemostasia se segmenta aún más en analizadores de laboratorio y sistemas de pruebas en el punto de atención. En 2021, el segmento de analizadores de laboratorio tiene la mayor participación de mercado y se estima que el segmento de sistemas de pruebas en el punto de atención registrará la CAGR más alta durante 2021-2028.

Cuota de mercado de analizadores de hemostasia, por Tipo de producto: 2021 y 2028

Información basada en pruebas

Según las pruebas, el mercado se segmenta en tiempo de tromboplastina parcial activada, prueba de dímero D, prueba de fibrinógeno, prueba de tiempo de protrombina, y otros. En 2021, el segmento de tiempo de tromboplastina parcial activada tuvo la mayor participación del mercado. Se espera que el segmento de pruebas de tiempo de protrombina registre la CAGR más alta del mercado durante 2021-2028.

Información basada en el usuario final

Según los usuarios finales, el mercado se segmenta en hospitales /clínicas, laboratorios de diagnóstico independientes, entornos de atención domiciliaria y otros. En 2021, el segmento de hospitales/clínicas representó la mayor parte del mercado. Se espera que el segmento de laboratorios de diagnóstico independientes registre la CAGR más alta del mercado durante 2021-2028.

Las empresas que operan en el mercado de analizadores de hemostasia enfatizan la adopción de la estrategia de innovaciones de productos para satisfacer las demandas cambiantes de los clientes en todo el mundo, que también les permite mantener su marca en el mercado global.

Mercado de analizadores de hemostasia: ndash; Segmentación

El mercado de analizadores de hemostasia está segmentado según el tipo de producto, la prueba y el usuario final. Según el tipo de producto, el mercado de analizadores de hemostasia se segmenta en analizadores de laboratorio y sistemas de pruebas en el punto de atención. Según las pruebas, el mercado se segmenta aún más en tiempo de tromboplastina parcial activada, prueba de dímero D, prueba de fibrinógeno, prueba de tiempo de protrombina y otras. Según el usuario final, el mercado se segmenta en hospitales/clínicas, laboratorios de diagnóstico independientes, entornos de atención domiciliaria y otros. En términos geográficos, el mercado de analizadores de hemostasia está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Francia, Alemania, Italia, Reino Unido, España y el resto de Europa), Asia Pacífico (Australia, China). , India, Japón, Corea del Sur y el resto de APAC), Medio Oriente y Asia. África (Arabia Saudita, Sudáfrica, Emiratos Árabes Unidos y el resto de MEA) y América del Sur y Central (Brasil, Argentina y el resto de SCAM)

Perfiles de empresas

  • Siemens AG
  • Laboratorio de instrumentación
  • Abbott
  • Sysmex Corporation
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Diagnostica Stago
  • Laboratorios Helena
  • Corporación Internacional Technidyne.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is hemostasis analyzers?

Hemostasis analyzers are medical devices that are used to measure the clotting time of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.

What are the factors impacting the Hemostasis Analyzers market?

The factors driving and restraining the hemostasis analyzers market in the coming years include the high prevalence of cardiovascular diseases and the rise in the geriatric population. However, the high cost of a fully automated hemostasis analyzer is likely to hamper the market's growth.

Who are the major players in the hemostasis analyzers market?

The hemostasis analyzers market majorly consists of the players such as Siemens AG, Instrumentation Laboratory, Abbott, Sysmex Corporation, Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Diagnostica Stago, Helena Laboratories, International Technidyne Corporation are amongst others.

What is the market value of the hemostasis analyzers market based on region?

The global hemostasis analyzers market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In the North America region, the market for hemostasis analyzers market is primarily held by the US among the other countries. The growth of the hemostasis analyzers market in the United States is expected to grow owing to increasing organic developments by the market players in the market, rising awareness among consumers for treatment, and an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases.

Which is the most influencing segment growing in the hemostasis analyzers market report?

The global hemostasis analyzers market based on product is segmented into product type [laboratory analyzer (automated systems, semi-automated systems, and manual systems) and point-of-care testing systems. In 2021, the laboratory analyzer segment held the largest share of the market by product and point-of-care testing systems is expected to witness the fastest CAGR during 2021 to 2028.

Which region is expected to witness significant demand for the hemostasis analyzers market in the coming years?

The Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to the rising development in the pharmaceutical sector. Also, the rise in the incidence of cardiovascular diseases is likely to provide more significant growth opportunities to the market players in the coming years is likely to boost the growth of the market in the Asia Pacific region.

The List of Companies - Hemostasis Analyzers Market

  1. Siemens AG
  2. Instrumentation Laboratory
  3. Abbott
  4. Sysmex Corporation
  5. Nihon Kohden Corporation
  6. Thermo Fisher Scientific Inc.
  7. Roche Diagnostics
  8. Diagnostica Stago
  9. Helena Laboratories
  10. International Technidyne Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports